Great news! The IP7-PACIFIC Protocol paper has been published 😍 take a look... 👀 sciencedirect.com/science/articl… Imperial Prostate Jon Aning NBT_BUI Research at North Bristol NHS Trust Rebecca Cousins Marta Cobos-Arrivabene

📣 Editorial spotlight: RSIrs could revolutionize prostate MRI by offering objective, accessible csPCa detection—reducing reliance on expert radiologists. When paired with PI-RADS and clinical data, it enhances accuracy and efficiency. #AUA Read more: bit.ly/3HbWe5u

Providing MRI quality is good, this is a no-brainer for the primary diagnostic setting. Here’s what internationally renowned experts think of the findings and why practice should change NOW 4/4:

PRIME trial: Biparametric MRI (no contrast) caught significant prostate cancer as well as full multiparametric scans. Shorter, cheaper, safer, could reset the standard of care worldwide? #ProstateCancer #Oncology doi:10.1001/jama.2025.13722 JAMA Advanced Prostate Cancer Consensus Conference Prostate Cancer Foundation

We still use contrast, but not according to PI-RADS, which is meant KISS (Keep It Simple Stupid). We use curve evaluation like Breast MRI. Curve 3 (looks like artery), is prognostic for a Gleason 4 component. This is especially helpfunctie in large TZ cancers.

🚨#ProstateCancer Focal Therapy Biomarker🚨 🧵1/8 "Genomic Biomarker for Prostate Cancer Focal Therapy: Post Hoc Assessment of a Phase II Clinical Trial" ✒️ JCO Precision Oncology Open access🔗 shorturl.at/nBTSk Department of Urology at Cedars-Sinai Cedars-Sinai UCLA Jonsson Comprehensive Cancer Center Cancer at Cedars-Sinai

Prostate-Specific Antigen Levels Among Participants Receiving Annual Testing jamanetwork.com/journals/jamao… This retrospective analysis of the PLCO Cancer Screening Trial examined yearly PSA variability in over 11,000 men undergoing annual screening. The study found that a substantial

WATCH🎥: Stephen J. Freedland, MD, (Stephen Freedland, MD) discusses the link between diet and prostate cancer, emphasizing 2 primary biological mechanisms: insulin signaling and inflammation. Department of Urology at Cedars-Sinai urologytimes.com/view/dietary-p…

Fascinating talks on AI in prostate MRI & histopathology from Profs Henkjan Huisman & Pekka Ruusuvuori For AI to succeed we need: •Trust •Benchmarking •Effective collaboration •Adequate segregation of commercial & scientific interests! #NordicPrecisionPCa #SPCG

🆕 in European Urology (Editor’s Choice) Systematic review of MRI in prostate cancer screening: ✔ Improves detection of clinically significant PCa ✔ Cuts unnecessary biopsies ✔ Best results with 2nd-stage MRI after PSA Full text 👉buff.ly/wILefD8 #ProstateCancer #MRI

Not all UTIs need immediate antibiotics. EAU survey: only 8% knew that ~30–40% of cases may resolve without immediate antibiotics. Guidelines support careful prescribing & shared decision-making. #UrologyWeek may be ending, but awareness must continue from clinic to community.

🆕 Editorial in European Urology by Sigrid Carlsson: MRI can reshape prostate cancer screening. 🔹 First-line MRI: ↑ detection, ↑ resource use 🔹 2nd-stage MRI after PSA: ↓ unnecessary biopsies, ↑ csPCa yield 🔹 Quality & risk-adapted pathways are key Read 👉

💫🌟🚨 NEW in NEJM Adjuvant Pembrolizumab vs Observation in MIUC 📘 #Alliance A031501 / #AMBASSADOR Trial 🧪 N=702 | Median follow-up: 44.8 months 🔗 nejm.org/doi/full/10.10… 🎓 Andrea Apolo, M.D., Petros Grivas, Guru P. Sonpavde, MD, Stephanie Berg, William Y. Kim, Bradley McGregor, Suzanne Cole, MD, FACP, FASCO,

#FocalTherapy “aims to spare men the incontinence, impotence and even penile shortening that have made treating #ProstateCancer one of the most controversial and polarizing fields in medicine.” Read the interview with Hashim U. Ahmed in Bloomberg UK: tinyurl.com/ts9n3pv2

Magnetic Resonance Imaging–based Biopsy Strategies in Prostate Cancer Screening: A Systematic Review sciencedirect.com/science/articl… Systematic review evaluated the benefit–harm balance of incorporating magnetic resonance imaging (MRI) into #ProstateCancer (PCa) screening as either a

#TRANSFORM will be opening very soon! Our Trial Management Group met last week to discuss the final plans before recruitment begins.

That’s where #TRANSFORM comes in. We will test several different approaches aiming to reduce these harms whilst detecting the most serious cancers.

The Fight to Fix Prostate Cancer Care For decades, men with the disease faced a binary choice: live with the cancer, or live with the consequences of removing it. S&C's Prof Hashim Ahmed discusses what could be a more precise & humane alternative ⬇️ bloomberg.com/news/articles/…

Turns out there’s no role of radical treatments in a balloon debate for TZ intermediate unfavourable PCa at #FOCAL2025

Bryant_Lab takes us through the TRANSLATE Trial at #FOCAL2025 LATP vs TRUS biopsy RCT ✅ 97% recruitment acceptance ✅ ⬆️ GGG2+ in LATP 🟰 for GGG3+ in LATP ❓ similar infection rates (NB abx use for TRUS not LATP)